BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• 

  Drug Development

  Tweaks to bluebird bio’s Gene Therapy Approach May be Working

  Bluebird is making forays into the CAR-T immuno-oncology market, although it has yet to bring a product to market.

  November 1, 2017

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Secretive Moderna Inks mRNA Heart Failure Deal With AstraZeneca

  The companies will advance the new Relaxin development candidate, AZD7970, toward the clinic as an investigational treatment for heart failure.

  November 1, 2017

   · 

  4 min read
• 

  Deals

  Novartis Considers Selling Its $1B+ Dermatology Generics Biz

  Days after plunking down $3.9B+ for AAA, Novartis may be looking to divest itself of its generic dermatology drug business.

  November 1, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Policy

  Top Mylan Exec Targeted in Price-Fixing Suit

  Mylan’s second-ranked exec allegedly took an active role in a vast and “sinister” price-fixing conspiracy among global makers of generic pills.

  November 1, 2017

   · 

  1 min read
• 

  Biotech Bay

  Bay Area’s AvidBiotics Splits Into Two Biotech Companies

  AvidBiotics is splitting into two separate companies and has developed two separate but similar technology platforms.

  November 1, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Business

  Cryogenic Logistics Company CryoPort Grabs Contracts for Gilead, Novartis CAR-T Products

  CryoPort handles the products for more than 172 of the more than 800 immunotherapy trials underway.

  November 1, 2017

   · 

  3 min read

   · 

  Alex Keown
• Business

  Arbutus Announces Conference Call to Provide a Corporate Update and Third Quarter 2017 Financial Results

  The company will host a conference call to provide a corporate update.

  November 1, 2017

   · 

  1 min read
• 

  Deals

  Halyard Health Unloads S&IP Biz to Owens & Minor for $710M

  Shares of Halyard Health are up more than 12 percent after the company announced it was selling its S&IP business to Owens & Minor for $710M.

  November 1, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Biotech Bay

  Biotechs Salivate as Bay Area VC Firm Banks $419M for Early Life Science R&D

  Frazier announced the closing of a $419M fund aimed solely at the industry.

  November 1, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Novartis Scientist Wounded in NYC Terrorist Attack That Killed Eight People

  The scientist was among the nearly one dozen people injured on Oct. 31.

  November 1, 2017

   · 

  2 min read

   · 

  Alex Keown